Leading by Experience! As a manufacturer of Semaglutide for future generic and innovative formulations, we have all the answers. It is currently used as an active pharmaceutical ingredient in prescription medicines for the treatment of type II diabetes and Obesity.
From a chemical point of view, Semaglutide is a peptide, which means it is a chain of amino acids.
Semaglutide can regulate our blood sugar level and appetite, reducing the risk of long-term damage in type II diabetes and obese patients. It is well known for its effectiveness and patient tolerability for both indications.
Featuring Kira Mounier, Sales Manager Generics, Global Sales Generics, Bachem
Contact the experts today: go.bachem.com/...
More about our generic APIs: go.bachem.com/...
---------------------------------------------------------------------------------------------------------------------------
About Bachem:
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides.
The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
Learn more about our products and services at bit.ly/3LykCeY
11 окт 2024
